Research compound profile

Tirzepatide

Dual receptor agonist research compoundInvestigational peptide30 MG

An investigational peptide studied in laboratory models involving GIP and GLP-1 receptor signaling.

Interactive vial preview

VERTEX
360° modelDocumented presentation · 60 × 20 MM · Ø 20 MM

Drag to rotate the vial

Research context

Published and preclinical work discusses this compound in relation to the pathways listed here. This summary does not establish clinical safety, efficacy or an approved use.

Areas of investigation

  • Dual-receptor signaling
  • Metabolic research
  • Analytical characterization

Evidence standard

Vertex analytical results are displayed only when a report can be mapped to the tested identity, amount and relevant lot. Supplier reference reports remain explicitly marked as reference-only.

Supplier reference reports
  • #123809

Handling of information

Information is provided for laboratory identification and research documentation. No dosage, administration or human-use guidance is provided.

Verify a labeled unit